Skip to main content
Figure 2 | Cardiovascular Diabetology

Figure 2

From: A pilot study of the efficacy of miglitol and sitagliptin for type 2diabetes with a continuous glucose monitoring system and incretin-related markers

Figure 2

Time course of CGM measured glucose (A), insulin (B), I/G(insulin to CGM measured glucose ratio) (C), glucagon (D), active GLP-1 (E), and GIP (F) levels before and after meal intake in the patient in case 1. The clear squares indicate no medication, filled squares indicate miglitol administration, and filled triangles indicate coadministration of miglitol and sitagliptin.

Back to article page